Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-01-24

FDA Approved: AVEED — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AVEED, the testosterone undecanoate product from Endo USA, Inc., updating the label based on submitted data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVEED (Testosterone undecanoate)

Snippet

SUPPL AP for AVEED (TESTOSTERONE UNDECANOATE)